Recurrent pneumonia in a patient with new coronavirus infection after discharge from hospital for insufficient antibody production: a case report

Abstract Background The rapid spread of coronavirus disease 2019 (COVID-19) was declared as an emerging public health threat by the World Health Organization. As various measures have been taken successfully to combat the epidemic caused by SARS-CoV-2, a growing number of fully recovered patients ha...

Full description

Bibliographic Details
Main Authors: Xiaoxi Zhou, Jianfeng Zhou, Jianping Zhao
Format: Article
Language:English
Published: BMC 2020-07-01
Series:BMC Infectious Diseases
Subjects:
Online Access:http://link.springer.com/article/10.1186/s12879-020-05231-z
id doaj-1ede8eb965f046698bcf4ce8f750ded0
record_format Article
spelling doaj-1ede8eb965f046698bcf4ce8f750ded02020-11-25T03:35:02ZengBMCBMC Infectious Diseases1471-23342020-07-012011410.1186/s12879-020-05231-zRecurrent pneumonia in a patient with new coronavirus infection after discharge from hospital for insufficient antibody production: a case reportXiaoxi Zhou0Jianfeng Zhou1Jianping Zhao2Department of Hematology, Tongji Hospital, Tongji Medical College, Huazhong University of Science and TechnologyDepartment of Hematology, Tongji Hospital, Tongji Medical College, Huazhong University of Science and TechnologyDepartment of Respiration, Tongji Hospital, Tongji Medical College, Huazhong University of Science and TechnologyAbstract Background The rapid spread of coronavirus disease 2019 (COVID-19) was declared as an emerging public health threat by the World Health Organization. As various measures have been taken successfully to combat the epidemic caused by SARS-CoV-2, a growing number of fully recovered patients have been discharged from hospitals. However, some of them have relapsed. Little is known about the causes that triggered the relapse. Case presentation We report a case of a 40 years old man who suffered from recurrent pulmonary infection with progression of lesions on chest computed tomography (CT), elevated levels of ferritin and IL2R, reduced lymphocyte count and positive oropharyngeal swab test for SARS-CoV-2 again after 5 days discharge from hospital. The anti-SARS-CoV-2 antibody level of this patient was very low at the time of relapse, suggesting a weak humoral immune response to the virus. Total exon sequencing revealed mutations in TRNT1 gene, which may be responsible for B cell immunodeficiency. Therefore, uncleared SARS-CoV-2 at his first discharge was likely to lead to his recurrence. However, viral superinfection and non-infectious organizing pneumonia could not be completely excluded. Conclusion COVID-19 relapse may occur in a part of discharged patients with low titers of anti-SARS-CoV-2 antibodies. These patients should be maintained in isolation for longer time even after discharge. A more sensitive method to detect SARS-CoV-2 needs to be established and serological testing for specific antibodies may be used as a reference to determine the duration of isolation.http://link.springer.com/article/10.1186/s12879-020-05231-zNew corona virusRecurrenceProtective antibodiesExtend isolation timeCase report
collection DOAJ
language English
format Article
sources DOAJ
author Xiaoxi Zhou
Jianfeng Zhou
Jianping Zhao
spellingShingle Xiaoxi Zhou
Jianfeng Zhou
Jianping Zhao
Recurrent pneumonia in a patient with new coronavirus infection after discharge from hospital for insufficient antibody production: a case report
BMC Infectious Diseases
New corona virus
Recurrence
Protective antibodies
Extend isolation time
Case report
author_facet Xiaoxi Zhou
Jianfeng Zhou
Jianping Zhao
author_sort Xiaoxi Zhou
title Recurrent pneumonia in a patient with new coronavirus infection after discharge from hospital for insufficient antibody production: a case report
title_short Recurrent pneumonia in a patient with new coronavirus infection after discharge from hospital for insufficient antibody production: a case report
title_full Recurrent pneumonia in a patient with new coronavirus infection after discharge from hospital for insufficient antibody production: a case report
title_fullStr Recurrent pneumonia in a patient with new coronavirus infection after discharge from hospital for insufficient antibody production: a case report
title_full_unstemmed Recurrent pneumonia in a patient with new coronavirus infection after discharge from hospital for insufficient antibody production: a case report
title_sort recurrent pneumonia in a patient with new coronavirus infection after discharge from hospital for insufficient antibody production: a case report
publisher BMC
series BMC Infectious Diseases
issn 1471-2334
publishDate 2020-07-01
description Abstract Background The rapid spread of coronavirus disease 2019 (COVID-19) was declared as an emerging public health threat by the World Health Organization. As various measures have been taken successfully to combat the epidemic caused by SARS-CoV-2, a growing number of fully recovered patients have been discharged from hospitals. However, some of them have relapsed. Little is known about the causes that triggered the relapse. Case presentation We report a case of a 40 years old man who suffered from recurrent pulmonary infection with progression of lesions on chest computed tomography (CT), elevated levels of ferritin and IL2R, reduced lymphocyte count and positive oropharyngeal swab test for SARS-CoV-2 again after 5 days discharge from hospital. The anti-SARS-CoV-2 antibody level of this patient was very low at the time of relapse, suggesting a weak humoral immune response to the virus. Total exon sequencing revealed mutations in TRNT1 gene, which may be responsible for B cell immunodeficiency. Therefore, uncleared SARS-CoV-2 at his first discharge was likely to lead to his recurrence. However, viral superinfection and non-infectious organizing pneumonia could not be completely excluded. Conclusion COVID-19 relapse may occur in a part of discharged patients with low titers of anti-SARS-CoV-2 antibodies. These patients should be maintained in isolation for longer time even after discharge. A more sensitive method to detect SARS-CoV-2 needs to be established and serological testing for specific antibodies may be used as a reference to determine the duration of isolation.
topic New corona virus
Recurrence
Protective antibodies
Extend isolation time
Case report
url http://link.springer.com/article/10.1186/s12879-020-05231-z
work_keys_str_mv AT xiaoxizhou recurrentpneumoniainapatientwithnewcoronavirusinfectionafterdischargefromhospitalforinsufficientantibodyproductionacasereport
AT jianfengzhou recurrentpneumoniainapatientwithnewcoronavirusinfectionafterdischargefromhospitalforinsufficientantibodyproductionacasereport
AT jianpingzhao recurrentpneumoniainapatientwithnewcoronavirusinfectionafterdischargefromhospitalforinsufficientantibodyproductionacasereport
_version_ 1724555963946500096